Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Search results for

There are 21,253 results that match your search.21,253 results
  • nohlen-nov02.jpg
    Less is more for equivalents
    In a series of four decisions rendered recently by the German Federal Supreme Court (BGH), the Court considered the extent to which the doctrine of equivalents applies to patent claims reciting numerical ranges: BGH GRUR 2002, 515 - Schneidmesser I (in English, Cutting Knife I); 519 - Schneidmesser II; 523 - Custodiol I; 527 - Custodiol II.
    Managing IP Correspondent, November 01, 2002
  • Freedom of expression upheld
    A UK court has upheld freedom of expression over privacy in the high profile case of supermodel Naomi Campbell, which interpreted the Data Protection Act for the first time.
    Managing IP Correspondent, November 01, 2002
  • dpg-usforeignorig-nov02.gif
    An underdog that bites
    James Hamilton, Philippe Signore and Christopher Ward explain why design patents are becoming more popular as a means of protection in the US
    Managing IP Correspondent, November 01, 2002
  • The month in words
    For all trade marks owners in the US, this will remove a competitive disadvantage
    Managing IP Correspondent, November 01, 2002
  • BMS faces pressure in Thailand
    An action to revoke its patent on the drug Videx EC threatens to limit further Bristol-Myers Squibb's (BMS) rights to sell Aids medicines in Thailand. Three Aids patients and the Foundation for Consumers, a local group, claim that the US pharmaceutical company did not invent the drug and so should not be allowed to own the rights to it in Thailand. According to the plaintiffs, the drug is a product of collaboration between BMS and the US National Institutes of Health (NIH).
    Managing IP Correspondent, November 01, 2002
  • lee-nov02.jpg
    Survey: Europe: Cracks show in trade mark traditions
    Following last year's Baby-Dry decision, trade mark attorneys in Europe have been exploring how to protect novel marks. The new Community Design gives them another tool. Ingrid Hering reports
    Managing IP Correspondent, November 01, 2002
  • Trade mark system strives to be taken seriously
    A new law and the strict implementation of a plan to speed up litigation have seen Indonesia move closer towards international standards of trade mark protection and enforcement, claim Adolf Panggabean and Erna L Kusoy
    Managing IP Correspondent, November 01, 2002
  • bae-nov02.jpg
    What estoppel means in Korea after Festo
    In July 2000, the Korean Supreme Court handed down its first decision specifically stating the requirements for the doctrine of equivalents. Afterwards, many other relevant precedent cases have also been decided in a rather short period of time.
    Managing IP Correspondent, November 01, 2002
  • rasser-nov02.jpg
    European and US patent protection compared
    As European politicians consider fundamental reforms to patent protection, one of the key questions they have to address is how to make the system more efficient. In particular, some critics believe Europe needs to look to the US model to improve its effectiveness. In a special MIP debate, Koos Rasser argues that the European patent system as it exists today is substantially inferior to that of the US, while Simon Mounteney says that, though not perfect, Europe offers many benefits to applicants
    Managing IP Correspondent, November 01, 2002
  • prilosec-nov02.jpg
    AstraZeneca's purple pill under threat
    Pharma company AstraZeneca has stopped three generics from launching rival versions of its multi-billion dollar drug Prilosec in the US. But a fourth generic company is free to manufacture its own version of the drug.
    Managing IP Correspondent, November 01, 2002
Previous
1
...
2005
2006
2007
2008
2009
...
2125
Next